Toll-Like Receptor 4 Deficiency Increases Disease and Mortality after Mouse Hepatitis Virus Type 1 Infection of Susceptible C3H Mice

ABSTRACT Severe acute respiratory syndrome (SARS) is characterized by substantial acute pulmonary inflammation with a high mortality rate. Despite the identification of SARS coronavirus (SARS-CoV) as the etiologic agent of SARS, a thorough understanding of the underlying disease pathogenesis has been hampered by the lack of a suitable animal model that recapitulates the human disease. Intranasal (i.n.) infection of A/J mice with the CoV mouse hepatitis virus strain 1 (MHV-1) induces an acute respiratory disease with a high lethality rate that shares several pathological similarities with SARS-CoV infection in humans. In this study, we examined virus replication and the character of pulmonary inflammation induced by MHV-1 infection in susceptible (A/J, C3H/HeJ, and BALB/c) and resistant (C57BL/6) strains of mice. Virus replication and distribution did not correlate with the relative susceptibilities of A/J, BALB/c, C3H/HeJ, and C57BL/6 mice. In order to further define the role of the host genetic background in influencing susceptibility to MHV-1-induced disease, we examined 14 different inbred mouse strains. BALB.B and BALB/c mice exhibited MHV-1-induced weight loss, whereas all other strains of H-2b and H-2d mice did not show any signs of disease following MHV-1 infection. H-2k mice demonstrated moderate susceptibility, with C3H/HeJ mice exhibiting the most severe disease. C3H/HeJ mice harbor a natural mutation in the gene that encodes Toll-like receptor 4 (TLR4) that disrupts TLR4 signaling. C3H/HeJ mice exhibit enhanced morbidity and mortality following i.n. MHV-1 infection compared to wild-type C3H/HeN mice. Our results indicate that TLR4 plays an important role in respiratory CoV pathogenesis.

[1]  S. Fukushi,et al.  Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice , 2008, The American Journal of Pathology.

[2]  Arthur S Slutsky,et al.  Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury , 2008, Cell.

[3]  R. Baric,et al.  Animal models and vaccines for SARS-CoV infection , 2007, Virus Research.

[4]  Alan D. Roberts,et al.  Aging and CD8+ T cell immunity to respiratory virus infections , 2007, Experimental Gerontology.

[5]  A. Heinzmann,et al.  TLR-4 and CD14 Polymorphisms in Respiratory Syncytial Virus Associated Disease , 2007, Disease markers.

[6]  Ralph Baric,et al.  A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.

[7]  G. Downey,et al.  MurineHepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J Mice , 2006, Journal of Virology.

[8]  S. Swain,et al.  Why Aging T Cells Fail: Implications for Vaccination , 2006, Immunity.

[9]  A. Oron,et al.  Lipopolysaccharide hyporesponsiveness as a risk factor for intensive care unit hospitalization in infants with respiratory syncitial virus bronchiolitis , 2006, Clinical and experimental immunology.

[10]  Jonathan H. Epstein,et al.  Bats Are Natural Reservoirs of SARS-Like Coronaviruses , 2005, Science.

[11]  C. Taube,et al.  Strain‐specific differences in perivascular inflammation in lungs in two murine models of allergic airway inflammation , 2005, Clinical and experimental immunology.

[12]  K. Subbarao,et al.  Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly Humans , 2005, Journal of Virology.

[13]  Samson S. Y. Wong,et al.  Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia , 2005, Journal of Virology.

[14]  John Bechill,et al.  Identification of Severe Acute Respiratory Syndrome Coronavirus Replicase Products and Characterization of Papain-Like Protease Activity , 2004, Journal of Virology.

[15]  R. Crystal,et al.  Resolution of Primary Severe Acute Respiratory Syndrome-Associated Coronavirus Infection Requires Stat1 , 2004, Journal of Virology.

[16]  A. Gigliotti,et al.  Inhaled diesel engine emissions reduce bacterial clearance and exacerbate lung disease to Pseudomonas aeruginosa infection in vivo. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  B. Murphy,et al.  Mechanisms of Host Defense following Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Pulmonary Infection of Mice , 2004, The Journal of Immunology.

[18]  N. Amariglio,et al.  Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. , 2004, The Journal of infectious diseases.

[19]  Michelle M. Packard,et al.  Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.

[20]  B. Berkhout,et al.  Identification of a new human coronavirus , 2004, Nature Medicine.

[21]  J. Sung,et al.  Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS) , 2004, Journal of Clinical Pathology.

[22]  J. Peiris,et al.  Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 , 2003, The Lancet.

[23]  Y. Guan,et al.  Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage , 2003, Journal of Molecular Biology.

[24]  P. Hawkey,et al.  Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. , 2003, Journal of medical microbiology.

[25]  Xin Li,et al.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.

[26]  W. Travis,et al.  Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore , 2003, Human Pathology.

[27]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[28]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[29]  Yi Guan,et al.  Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.

[30]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[31]  K. Holmes,et al.  SARS-associated coronavirus. , 2003, The New England journal of medicine.

[32]  Malik Peiris,et al.  Aetiology: Koch's postulates fulfilled for SARS virus , 2003, Nature.

[33]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[34]  K. Stöhr A multicentre collaboration to investigate the cause of severe acute respiratory syndrome , 2003, The Lancet.

[35]  Arthur S Slutsky,et al.  Identification of severe acute respiratory syndrome in Canada. , 2003, The New England journal of medicine.

[36]  T. S. Moran,et al.  Acute Changes in Lung Histopathology and Bronchoalveolar Lavage Parameters in Mice Exposed to the Choking Agent Gas Phosgene , 2002, Toxicologic pathology.

[37]  P. Openshaw,et al.  Inhibition of tumor necrosis factor reduces the severity of virus‐specific lung immunopathology , 2001, European journal of immunology.

[38]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[39]  E. Gelfand,et al.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. , 1997, American journal of respiratory and critical care medicine.

[40]  T. Gallagher,et al.  Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein , 1996, Journal of virology.

[41]  L. Weiner,et al.  Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease☆ , 1987, Microbial Pathogenesis.

[42]  L. Weiner,et al.  Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies , 1986, Journal of virology.

[43]  L. Rorke,et al.  Experimental demyelination produced by the A59 strain of mouse hepatitis virus , 1984, Neurology.

[44]  L. Weiner,et al.  Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. , 1982, The Journal of general virology.

[45]  R. Knobler,et al.  Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4 , 1982, Nature.

[46]  D. Rosenstreich,et al.  Characterization of a congenitally LPS-resistant, athymic mouse strain. , 1979, Journal of immunology.

[47]  C. Andrewes,et al.  Production of hepatitis in mice by the combined action of two filterable agents. , 1952, Lancet.

[48]  J. Fleming,et al.  Pathogenesis of mouse hepatitis virus-induced demyelination. , 1996, Journal of neurovirology.